Star Health and Allied Insurance Company Limited (NSE: STARHEALTH)
India
· Delayed Price · Currency is INR 483.60
+8.40 (1.77%)
Dec 24, 2024, 3:30 PM IST
NSE: STARHEALTH Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Premiums & Annuity Revenue | 139,131 | 129,383 | 112,616 | 98,092 | 46,266 | 46,930 | Upgrade
|
| Total Interest & Dividend Income | 10,159 | 9,996 | 8,233 | 6,305 | 4,138 | 2,870 | Upgrade
|
| Gain (Loss) on Sale of Investments | 2,126 | 844.74 | 112.35 | 1,623 | 99.26 | -32.76 | Upgrade
|
| Other Revenue | 12.87 | 18.17 | 38.6 | 13.71 | 3.21 | 0.33 | Upgrade
|
| Total Revenue | 151,429 | 140,242 | 121,000 | 106,034 | 50,506 | 49,768 | Upgrade
|
| Revenue Growth (YoY) | -17.24% | 15.90% | 14.11% | 109.94% | 1.48% | 32.17% | Upgrade
|
| Policy Benefits | 94,842 | 85,999 | 73,204 | 85,400 | 43,695 | 30,874 | Upgrade
|
| Policy Acquisition & Underwriting Costs | 19,759 | 18,537 | 16,828 | 14,922 | 5,858 | 3,409 | Upgrade
|
| Selling, General & Administrative | 24,490 | 23,599 | 20,310 | 18,221 | 14,736 | 11,057 | Upgrade
|
| Provision for Bad Debts | 22.93 | 25.13 | 10.96 | 26.17 | 345.47 | 10.06 | Upgrade
|
| Other Operating Expenses | -20.17 | -17.67 | -9.44 | - | - | - | Upgrade
|
| Total Operating Expenses | 139,104 | 128,152 | 111,850 | 119,323 | 64,648 | 45,350 | Upgrade
|
| Operating Income | 12,325 | 12,090 | 9,150 | -13,289 | -14,141 | 4,418 | Upgrade
|
| Interest Expense | -800.49 | -801.39 | -884.19 | -720.06 | -283.66 | -283.97 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.45 | 2.15 | 0.41 | 56.72 | -0.6 | -0.6 | Upgrade
|
| EBT Excluding Unusual Items | 11,522 | 11,290 | 8,267 | -13,953 | -14,426 | 4,133 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.36 | -1.84 | -2.47 | -13.63 | -32.35 | 1.31 | Upgrade
|
| Pretax Income | 11,524 | 11,288 | 8,264 | -13,966 | -14,458 | 4,134 | Upgrade
|
| Income Tax Expense | 2,903 | 2,838 | 2,078 | -3,560 | -3,601 | 1,454 | Upgrade
|
| Net Income | 8,621 | 8,450 | 6,186 | -10,407 | -10,857 | 2,680 | Upgrade
|
| Net Income to Common | 8,621 | 8,450 | 6,186 | -10,407 | -10,857 | 2,680 | Upgrade
|
| Net Income Growth | 18.85% | 36.60% | - | - | - | 109.01% | Upgrade
|
| Shares Outstanding (Basic) | 585 | 583 | 578 | 558 | 499 | 479 | Upgrade
|
| Shares Outstanding (Diluted) | 595 | 596 | 594 | 558 | 499 | 489 | Upgrade
|
| Shares Change (YoY) | -0.08% | 0.22% | 6.50% | 11.78% | 1.99% | 6.00% | Upgrade
|
| EPS (Basic) | 14.74 | 14.48 | 10.70 | -18.65 | -21.75 | 5.59 | Upgrade
|
| EPS (Diluted) | 14.49 | 14.19 | 10.41 | -18.65 | -21.75 | 5.48 | Upgrade
|
| EPS Growth | 18.94% | 36.31% | - | - | - | 97.12% | Upgrade
|
| Free Cash Flow | - | 11,865 | 12,292 | -75.67 | 8,443 | 6,137 | Upgrade
|
| Free Cash Flow Per Share | - | 19.92 | 20.69 | -0.14 | 16.91 | 12.54 | Upgrade
|
| Operating Margin | 8.14% | 8.62% | 7.56% | -12.53% | -28.00% | 8.88% | Upgrade
|
| Profit Margin | 5.69% | 6.03% | 5.11% | -9.81% | -21.50% | 5.39% | Upgrade
|
| Free Cash Flow Margin | - | 8.46% | 10.16% | -0.07% | 16.72% | 12.33% | Upgrade
|
| EBITDA | 12,409 | 12,319 | 9,671 | -12,856 | -13,684 | 4,559 | Upgrade
|
| EBITDA Margin | 8.19% | 8.78% | 7.99% | -12.12% | -27.09% | 9.16% | Upgrade
|
| D&A For EBITDA | 84.1 | 229.62 | 520.67 | 432.99 | 457.3 | 141.78 | Upgrade
|
| EBIT | 12,325 | 12,090 | 9,150 | -13,289 | -14,141 | 4,418 | Upgrade
|
| EBIT Margin | 8.14% | 8.62% | 7.56% | -12.53% | -28.00% | 8.88% | Upgrade
|
| Effective Tax Rate | 25.19% | 25.14% | 25.15% | - | - | 35.18% | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.